Leucocytoclastic vasculitis associated with golimumab

Rheumatology (United Kingdom)

Volumn 52, Issue 10, 2013, Pages 1921-1923

  Pàmies, Anna ^a,b   Castro, Sonia ^a   Poveda, Maria J ^a   Fontova, Ramon ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL VERGE DE LA CINTA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GOLIMUMAB;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; DISEASE ACTIVITY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; LEUKOCYTOCLASTIC VASCULITIS; PRIORITY JOURNAL; PROGNOSIS; PURPURA; SKIN BIOPSY; TREATMENT RESPONSE;

EID: 84887363887     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket125     Document Type: Letter

References (9)

1. Keystone EC, Genovese MC, Klareskog L et al. Golimumab, a human antibody to tumour necrosis factor a given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis 2009;68:789-96.
2. Inman RD, Davis JC Jr, Heijde D et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 2008;58:3402-12.
3. Kavanaugh A, McInnes I, Mease P et al. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum 2009;60:976-86.
4. Mohan N, Edwards ET, Cupps TR et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 2004;31:1955-8.
5. Ramos-Casals M, Brito-Zerón P, Muñoz S et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine 2007;86:242-51.
6. Fujikawa K, Kawakami A, Hayashi T et al. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases. Mod Rheumatol 2010;20:86-9.
7. Peeters AJ, van den Wall Bake AW, Daha MR et al. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Ann Rheum Dis 1990;49:638-40.
8. Beauvais C, Kaplan G, Mougenot B et al. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. Ann Rheum Dis 1993;52:61-2.
9. Guillevin L, Mouthon L. Tumor necrosis factor-a blockade and the risk of vasculitis. J Rheumatol 2004;31:1885-7.